These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Lipoxygenase inhibition: the neglected frontier for regulating chronic inflammation and pain. Whitehouse MW; Rainsford KD Inflammopharmacology; 2006 Aug; 14(3-4):99-102. PubMed ID: 16983490 [No Abstract] [Full Text] [Related]
65. [From chronic inflammation to metastasizing colon cancer--the endless story of the NSAIDs]. Allgayer H; Kruis W Z Gastroenterol; 2006 Jul; 44(7):611-3. PubMed ID: 16823704 [No Abstract] [Full Text] [Related]
66. Inflammation unveiled: five new studies pave the way. Researchers are zeroing in on the complex role inflammation plays in many diseases and disorders. Health News; 2006 Jan; 12(1):3-5. PubMed ID: 16447313 [No Abstract] [Full Text] [Related]
67. [Non-steroidal anti-inflammatories in dentistry. Advantages and prescription risks]. Gass M; Klein P Chir Dent Fr; 1988 Oct; 58(443):81-6. PubMed ID: 3268382 [No Abstract] [Full Text] [Related]
68. The mastocyte: the "other" inflammatory cell in immunopathogenesis. Mekori YA J Allergy Clin Immunol; 2004 Jul; 114(1):52-7. PubMed ID: 15241344 [No Abstract] [Full Text] [Related]
69. [Cardiovascular complications in immune mediated diseases]. Finckh A Rev Med Suisse; 2013 Mar; 9(377):549-50, 552, 554-5. PubMed ID: 23534241 [TBL] [Abstract][Full Text] [Related]
70. Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? Abdollahi E; Momtazi AA; Johnston TP; Sahebkar A J Cell Physiol; 2018 Feb; 233(2):830-848. PubMed ID: 28059453 [TBL] [Abstract][Full Text] [Related]
71. Dipyrone: The ban, the justification. Fehintola FA Afr J Med Med Sci; 2005 Dec; 34(4):403-4. PubMed ID: 16752674 [No Abstract] [Full Text] [Related]
73. COX-2 inhibitors in sports medicine: utility and controversy. Buvanendran A; Reuben SS Br J Sports Med; 2006 Nov; 40(11):895-6. PubMed ID: 16950884 [TBL] [Abstract][Full Text] [Related]
74. Inflammation as an important feature of osteoarthritis. Brooks P Bull World Health Organ; 2003; 81(9):689-90. PubMed ID: 14710513 [No Abstract] [Full Text] [Related]
75. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Schwartz DM; Kanno Y; Villarino A; Ward M; Gadina M; O'Shea JJ Nat Rev Drug Discov; 2017 Dec; 16(12):843-862. PubMed ID: 29104284 [TBL] [Abstract][Full Text] [Related]
77. Genomic and systems approaches to translational biomarker discovery in immunological diseases. MacIsaac KD; Wang IM; Menetski J; Roberts C Drug Discov Today; 2014 Feb; 19(2):133-9. PubMed ID: 24126144 [TBL] [Abstract][Full Text] [Related]